The airway epithelium in asthma.


Journal

Advances in immunology
ISSN: 1557-8445
Titre abrégé: Adv Immunol
Pays: United States
ID NLM: 0370425

Informations de publication

Date de publication:
2019
Historique:
entrez: 13 7 2019
pubmed: 13 7 2019
medline: 16 4 2020
Statut: ppublish

Résumé

Asthma is a genetically and phenotypically complex disease that has a major impact on global health. Signs and symptoms of asthma are caused by the obstruction of airflow through the airways. The epithelium that lines the airways plays a major role in maintaining airway patency and in host defense. The epithelium initiates responses to inhaled or aspirated substances, including allergens, viruses, and bacteria, and epithelial-derived cytokines are important in the recruitment and activation of immune cells in the airway. Changes in the structure and function of the airway epithelium are a prominent feature of asthma. Approximately half of individuals with asthma have evidence of active type 2 immune responses in the airway. In these individuals, epithelial cytokines promote type 2 responses, and responses to type 2 cytokines result in increased epithelial mucus production and other effects that cause airway obstruction. Recent work also implicates other epithelial responses, including interleukin-17, interferon and ER stress responses, that may contribute to asthma pathogenesis and provide new targets for therapy.

Identifiants

pubmed: 31296301
pii: S0065-2776(19)30015-X
doi: 10.1016/bs.ai.2019.05.001
pii:
doi:

Substances chimiques

Alarmins 0
Allergens 0
Interleukin-13 0
Interleukin-17 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-34

Subventions

Organisme : NHLBI NIH HHS
ID : R35 HL145235
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI077439
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138424
Pays : United States

Informations de copyright

© 2019 Elsevier Inc. All rights reserved.

Auteurs

Luke R Bonser (LR)

Lung Biology Center, University of California San Francisco, San Francisco, CA, United States.

David J Erle (DJ)

Lung Biology Center, University of California San Francisco, San Francisco, CA, United States. Electronic address: david.erle@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH